SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17287478
Source:
http://linkedlifedata.com/resource/pubmed/id/17287478
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003250
,
umls-concept:C0033860
,
umls-concept:C0086418
,
umls-concept:C0087111
,
umls-concept:C0123759
pubmed:issue
6
pubmed:dateCreated
2007-2-8
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00320216
pubmed:abstractText
Skin-infiltrating lymphocytes expressing type 1 cytokines have been linked to the pathophysiology of psoriasis. We evaluated the safety and efficacy of a human interleukin-12/23 monoclonal antibody in treating psoriasis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17287478-17494940
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17287478-18177594
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors
,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12
,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-23
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1533-4406
pubmed:author
pubmed-author:CNTO 1275 Psoriasis Study Group
,
pubmed-author:DooleyLisa TLT
,
pubmed-author:GuzzoCynthiaC
,
pubmed-author:KruegerGerald GGG
,
pubmed-author:LangleyRichard GRG
,
pubmed-author:LebwohlMarkM
,
pubmed-author:LeonardiCraigC
,
pubmed-author:WangYuhuaY
,
pubmed-author:YeildingNewmanN
pubmed:copyrightInfo
Copyright 2007 Massachusetts Medical Society.
pubmed:issnType
Electronic
pubmed:day
8
pubmed:volume
356
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
580-92
pubmed:dateRevised
2008-1-29
pubmed:meshHeading
pubmed-meshheading:17287478-Adult
,
pubmed-meshheading:17287478-Antibodies, Monoclonal
,
pubmed-meshheading:17287478-Double-Blind Method
,
pubmed-meshheading:17287478-Female
,
pubmed-meshheading:17287478-Humans
,
pubmed-meshheading:17287478-Immunologic Factors
,
pubmed-meshheading:17287478-Interleukin-12
,
pubmed-meshheading:17287478-Interleukin-23
,
pubmed-meshheading:17287478-Male
,
pubmed-meshheading:17287478-Middle Aged
,
pubmed-meshheading:17287478-Psoriasis
,
pubmed-meshheading:17287478-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
pubmed:affiliation
University of Utah, Salt Lake City, USA. gerald.krueger@derm.med.utah.edu
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase II